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Background: Cichorium intybus is a medicinal plant commonly used in traditional medicine for its benefits in
immune-madiated disorders. There are several evidences showing that C. intybus can modulate immune responses.
In the present study we have investigated the effects of the ethanolic root extract of this plant on the immune
system by targeting dendritic cells (DCs). For this purpose, phenotypic and functional maturity of murine DCs after
treatment with the extract was analyzed by flow cytometry and mixed lymphocyte reaction (MLR) assay.
Results: C. intybus did not change the expression of CD40, CD86 and MHC-II molecules as important co-stimulatory
markers on DCs compared to the control, indicating that it could not promote DCs phenotypic maturation.
Treatment of DCs with lower concentrations of the extract resulted in an increased production of IL-12 by these
cells with no change in IL-10 release. The capacity of treated DCs to stimulate allogenic T cells proliferation and
cytokines secretion was examined in the co-cuture of these cells with T cells in MLR. C. intybus at higher
concentrations inhibited proliferation of allogenic T cells and in lower concentrations changed the level of cytokines
such that IL-4 decreased and IFN-γ increased.
Conclusions: These results indicated that C. intybus extract at higher concentrations can inhibit T cell stimulating
activity of DCs, whereas at lower concentrations can modulate cytokine secretion toward a Th1 pattern. These data
may in part explain the traditional use of this plant in treatment of immune-mediated disorders.
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The use of herbal medicine is increasing in therapies
of immune disorders, including autoimmune diseases
and cancers in all over the world. Cichorium intybus
(C. intybus) belonging to Asteraceae family, also known
as chicory, grows as a wild plant and is a well-known
herb with various biological activities. This plant is
native to Europe and Asia and has been widely used in
folk medicine for treatment of gallstones, appetite loss,
gout, jaundice, skin swellings, rheumatism and liver
inflammation [1,2]. The seed extract of C. intybus has
shown high antioxidant activity, short- and long-term
beneficial effects on diabetes [3] as well as ameliorating
effects on non-alcoholic fatty liver disease [4]. Methanolic
extract of C. intybus and its various fractions have revealed* Correspondence: amirghz@sums.ac.ir
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unless otherwise stated.wound healing effects. β-Sitosterol has been considered as a
main component of chicory extract in wound healing [5].
The methanolic extract of the plant has demonstrated some
anticancer and apoptosis inducing effects [5]. C. intybus
could ameliorate the oxidative stress, hepatic injury and
cellular damage induced by chemical compounds in rat
[6,7]. In addition, this plant has shown anti-inflammatory
activity by inhibiting TNF-α mediated inflammation and
reducing cyclooxygenase (COX)-2 protein expression
[1]. The ethanolic root extract of C. intybus has inhibited
mitogen-activated human lymphocyte proliferation as well
as allogenic T cell responses [8] which implies the ability
of this plant to modulate immune responses.
Dendritic cells (DCs), as the most potent antigen
presenting cells for naïve T cells, act as a link between the
acquired and innate immune systems and are responsible
for the initiation of the protective immune response as well
as the induction of immune tolerance [9]. The function of
these cells is affected by their maturation status, origin
and phenotype [10]. These cells have the unique abilitytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Th2 cells [11]. They can also effectively down-regulate
T-cell responses through the generation of T regulatory
cells [12]. DCs in immature forms can effectively present
antigen but because of low expression of co-stimulatory
molecules such as CD86, CD40 and MHC II they cannot
properly stimulate immune system [10]. T cells activation
and proliferation are inhibited and suppressed with re-
peated stimulation by immature DCs. Maturation of
DCs converts them to the cells that can stimulate immune
system vigorously. Therefore inhibition of this process is a
valuable strategy to modulate immune responses. In this
regard, using DCs with low expression of co-stimulatory
molecules can be considered as a beneficial approach in
therapy of autoimmune disease and transplantation [13].
For this reason, considerable studies have been performed
to use these cells as therapeutic targets for immunomodu-
latory effects of some pharmacological compounds.
Given the important role of DCs in immune response
as well as immune regulation and the presence of data
regarding the immunomodulatory effects of C. intybus,
we hypothesized that this plant might have some modula-
tory effects on DCs. To the best of our knowledge, there is
no study about the effect of C. intybus on DCs. Therefore
in the present study we have investigated the effects of the
root extract of this plant on the maturation and function
of DCs through evaluation of the expression of DC matur-
ation markers, their allostimulatory capacity and release of
the main Th1 and Th2 cytokines.
Materials and methods
Animals
6- week-old male BALB/c and C57BL/6 mice were pur-
chased from Razi Institute (Shiraz, Iran) and were kept
under optimal conditions of hygiene and received standard
mouse chow and water ad libitum. All experimental proce-
dures on handling the animals were approved by the ethical
committee of Shiraz University of Medical Sciences.
Purification of splenic DCs
In order to isolate DCs from spleen, the gradient media
(Nycodenz, Axis Shields, Norway) was used as previously
described [14]. Briefly, mice spleens were chopped and
digested with 1 mg/ml collagenase D (Roche, Germany)
and 0.02 mg/ml DNase (Roche) and meshed with 0.2 μm
sieve. Cells were washed with RPMI 1640 culture medium
(Sigma, St. Louis, MO, USA) containing 5 mM EDTA. The
pellet was resuspended in culture medium with 10% fetal
calf serum (FCS) and 5 mM EDTA. The cell suspension
was layered on Nycodenz 12.5% (w/v), d = 1.068 and centri-
fuged at 1800 rpm and 4°C for 20 min. The interface layer
was collected and washed two times and 1 × 104 cells cul-
tured in 3 cm plate for 2 h at 37°C in a 5% CO2 incubator.
After that, non-adherent cells were discarded by washingand adherent cells were used for tests. Purity of the ad-
herent cells was determined with analysis for the expres-
sion of CD11c molecule by flow cytometry. The cells were
routinely more than 90% CD11c positive.
Preparation of the ethanolic root extract of C. intybus
The roots of C. intybus were collected from Fars provinces
at October and authenticated by Mr Iraj Mehregan, from
Shiraz School of Pharmacy. A voucher specimen was
deposited in the Herbarium of the School of Pharmacy.
Samples were washed, dried and then 200 g of each shade
dried powder was extracted in a percolator containing
70% ethanol. After 72 h, percolation was done and the
extract solution was concentrated in a rotary evaporator
(Heidolph, Germany). The dried extract was dissolved
in dimethyl sulphoxide (DMSO) and then resuspended
in RPMI 1640 medium to obtain 20 mg/ml solution.
Treatment of DCs with the extract
DCs were treated with C. intybus extract at final concentra-
tions of 0.1, 1, 10 and 100 μg/ml in the cell culture plates.
As negative control, cells were treated with the vehicle
(DMSO) at the highest concentration used in the tests
(0.1%) and as positive control, cells were treated with
TNF-α (Sigma), the known DC maturation inducing
cytokine, at concentration of 40 ng/ml.
MTT cell viability assay
In vitro cytotoxicity of the extract on DCs was tested
by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT) colorimetric assay as described previously
[15]. DCs were treated with different concentrations of
the extract ranging from 0.1 to 100 μg/ml for 24 h, then
10 μl MTT (5 mg/ml, Sigma) was added to each well and
cells were incubated for an additional 4 h at 37°C. The
optical density (OD) of each well was measured at 570 with
reference at 630 nm on an enzyme-linked immuosorbent
assay (ELISA) plate reader. The viability was determined as
the follows: (OD of extract-treated cells/OD of DMSO-
treated cells) × 100.
Flow cytometry analysis
Isolated DCs were treated with non toxic concentrations
of the extract for 18 h and were then analyzed for the
expression of co-stimulatory molecules in a flow cyt-
ometer (FACSCalibur, Beckton Dickinson Biosciences,
San Jose, CA). Cells were stained with phycoerithrin
(PE)-conjugated anti-CD11c, fluorescence isothiocyanate
(FITC)-conjugated anti-CD40, FITC-conjugated anti-CD86
and FITC-conjugated anti-MHC II antibody and appro-
priate conjugated isotypes all from Beckton Dickinson
(BD) Pharminogen (San Diego, CA). Data were analyzed
using Win MDI software (Scripps, La Jolla, CA). The
ratio between the percentage of markers expression on






















Figure 1 Cell viability assay of C. intybus ethanolic extract on
DCs after 24 h treatment determined by MTT assay. Control was
DCs treated with DMSO at the highest concentrations used in the
tests (e.g., 0.1). The bars indicate mean ± standard deviation of three
independent experiments performed in triplicate. The extract had no
significant growth inhibitory effects on DCs.
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lated. The mean florescent intensity (MFI) of the expression
of markers on extract-treated DCs were also determined
and compared with DMSO-treated DCs.
Allogeneic mixed lymphocyte reaction (MLR)
In order to evaluate the proliferative effect of extract-
treated DCs on T lymphocytes, MLR assay was used. For
this, T cells were purified from lymph nodes of C57BL/6
mice using nylon wool. The purity was determined using
FITC-conjugated anti-CD3 antibody (BD Pharminogen) by
flow cytometry. C. intybus-treated DCs were inactivated
with mitomycin C (0.5 mg/ml) for 20 min, then cells
were washed with phosphate buffered saline (PBS) for three
times and resuspended in culture medium containing
10% FCS. For MLR assay, 104cells/well mitomycin-treated
DCs, as stimulator cells, were added in a 96-well round-
bottomed culture plate (Nunc, Denmark) in triplicates and
co-cultured with 105 allogenic T cells, as responder cells,
for 48 h. A triplicate wells containing DMSO-treated DCs
plus allogenic T cells were used as negative control. T cell
proliferation was measured by a 5-Bromo-20-deoxy-uridine
(BrdU) cell proliferation assay kit (Roche, Germany) ac-
cording to the manufacturer’s instructions. Proliferation
was determined as the follows: (OD of extract-treated
culture/OD of DMSO-treated culture) × 100.
Cytokines assay
The supernatant of extract-treated DCs and MLR cul-
tures were collected and used to measure IL-12, IFN-γ,
IL-10 and IL-4 by ELISA kits according to the manu-
facturer’s protocol (eBioscience, USA). The sensitivity
of IL-4, IFN- γ, IL-10 and IL-12 kits were 4, 15, 30 and
15 pg/ml, respectively.
Statistics analysis
All data were representative of at least three or two
independent experiments performed in triplicate and
presented as mean ± standard deviation (SD). The differ-
ences between groups were analyzed by Student’s t-test
and oneway ANOVA using Graph-Pad Prism 5 software
(Graph-Pad Software Inc, San Diego, CA). P vales less
than 0.05 were considered significant.
Results
Effects of C. intybus on viability of DCs
In order to determine the effects of C. intybus on the
viability of DCs, these cells were treated with different
concentrations of the plant extract for 24 h and then
MTT assay was performed. The results showed that
this extract at concentration of 0.1, 1, 10 and 100 μg/ml
had no cytotoxic effect on DCs (Figure 1), therefore
these concentrations were used for the next experi-
ments on DCs.Effect of C. intybus on maturation of mouse splenic DCs
C. intybus-treated DCs were analyzed by flow cytometry for
the expression of CD40, CD86 and MHC II co-stimulatory
molecules. As data in Figure 2A shows, the extract did
not significantly modulate the percentage expression of
these molecules at concentration of 0.1 to 100 μg/ml
(see Additional file 1: Figure S1 for dot plots). Although,
an increasing concentrations of the extract has led to a
decreasing MHC II fluorescence intensity of expression
(p < 0.01), none of the molecules MFI was significantly
different between the extract-treated cells and the cor-
responding control (Figure 2B).
Effect of C. intybus treated DCs on proliferation of T cells
In order to find the effects of the plant on DCs function,
mouse splenic DCs were treated with concentrations of
0.1 to 100 μg/ml of the extract for 18 h and then cells
were co-cultured with allogenic T cells in MLR assay.
The proliferation of T lymphocytes was evaluated using
BrdU incorporation assay. As results in Figure 3 show,
ethanolic extract of C. intybus decreased the proliferation
of T cells at higher concentrations. The proliferation of
these cells decreased to 75.60 ± 2.5 and 79.80 ± 6.1 per-
cent of control when DCs had been treated with 10
and 100 μg/ml of the extract, respectively (P < 0.05).
Effect of C. intybus-treated DCs on the production
of cytokines
The effect of the extract on IL-4 and IFN- γ production
in MLR is demonstrated in Figure 4A. A decreased IL-4
level in the supernatant of T cells co-cultured with
DCs treated with lower concentrations of C. intybus in
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Figure 2 Effect of C. intybus ethanolic extract on phenotypic maturation of DCs. DCs were treated with the extract for 18 h and then the
expression of CD40, CD86 and MHC II molecules was determined by flow cytomety. Negative control was DCs treated with DMSO. A) The bars
indicate mean ± SD of the ratio between the percentage of markers expression on DCs treated with the extract and those treated with DMSO.
B) The bars indicate mean ± SD of the mean fluorescence intensity (MFI) of the expression of markers. No significant difference in the ratio and
MFI of the markers expression between extract-treated DCs and control cells was observed.
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level of this cytokine was 12.98 ± 7.87 and 8 ± 2.51 pg/ml
at concentrations of 0.1 and 10 μg/ml of the extract, re-
spectively, compared to the control (32.04 ± 3.35 pg/ml).
Conversely, C. intybus at concentration of 1 μg/ml signifi-
cantly increased IFN-γ production in the supernatant of
MLR culture in comparison with the control.
Effects of C. intybus on IL-12 and IL-10 production by DCs
The level of IL-12 and IL-10 in the supernatant of
extract-treated DCs was measured. As the result in
Figure 4B shows, IL-12 level was significantly higher at
concentrations of 0.1 (280.6 ± 26.58 pg/ml) and 1 μg /ml of
the extract (195.5 ± 16.88 pg/ml) than the negative control(88.58 ± 23.87 pg/ml, P < 0.05). The level of IL-10 didn’t
show any significant differences in the supernatant of
extract-treated and DMSO-treated DCs.
Discussion
In various studies the ability of plants and their derivatives
to modulate DCs and induce changes in the expression of
co-stimulatory molecules, cytokine secretion patterns and
their T cell stimulating activity have been investigated
[16,17]. DCs, the key cells of antigen presentation are
considered as the important targets for immune response
as well as immune regulation.
C. intybus has been widely used as a remedy for treat-
ment of various inflammatory diseases. There are several


























Figure 3 The effect of DCs treated with C. intybus extract on T
cells proliferation in MLR assay. DCs were treated with the extract
for 18 h and then co-cultured with allogenic T cells for 48 h. Control
was DMSO-treated DCs plus T cells. Cell proliferation was measured
by Brdu incorporation assay. The bars indicate mean ± SD of the cell
proliferation in the presence of the extract as compared to the
proliferation of controls taken to be 100%. DCs treated with 10 and
100 μg/ml of extract have decreased T cells proliferation (**P < 0.01).
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Figure 4 Effect of C. intybus extract on cytokine production. (A) The e
was DMSO-treated DCs plus allogenic T cells. (B) The effect of the extract o
was DMSO- treated DCs. *P < 0.05, **P < 0.01, ***P < 0.001 shows significan
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inflammatory effects [1,7]. The root extracts of this
plant have shown anti-inflammatory properties in animal
models of arthritis. Moreover, in a clinical trial, the safety
and usefulness of a proprietary bioactive extract of its root
in patients with osteoarthritis have been demonstrated [18].
A decrease observed in macrophage migration inhibitory
factor (MIF) serum level in healthy volunteers consuming
Chicory coffee [19] and an inhibition in the expression
and activity of COX-2 by the ethyl acetate root extract
in human colon carcinoma HT29 cells treated with the
pro-inflammatory cytokine TNF-α are further evi-
dences implying the effectiveness of this plant on
modulation of immune mediators release [1].
As DCs have a critical role in inducing inflammation
as well as immune responses, in the present study we ar-
ranged a set of experiments to examine the effect of the
plant extract on maturation and function of splenic DCs.
The phenotypic maturation of DCs was investigated via
evaluation of the expression of CD40, CD86 and MHC- ІІ
molecules which are important co-stimulatory markers on
DCs and have critical roles in antigen presentation and T
cell activation. The extract revealed no significant effect
on the expression of CD40 and CD86 molecules, showing

































ffect of the extract on IL-4 and IFN- γ production in MLR assay. Control
n IL-12 and IL-10 secretion by extract treated-DCs after 18 h. Control
t difference with the negative control.
Karimi et al. DARU Journal of Pharmaceutical Sciences 2014, 22:28 Page 6 of 7
http://www.darujps.com/content/22/1/28of MHC II antigen on DCs was not also significantly differ-
ent with the control, however the intensity of expression of
this molecule showed a significant decrease by increasing
the concentration of the extract up to 100 μg/ml, indicating
a dose-dependent trend to reduce the expression of this
molecule on treated DCs as the extract concentration
is increased. Any decrease in the expression of the co-
stimulatory molecules like MHC II on DCs can be resulted
in failure of such DCs to provide an effective response for
T cells because these DCs are not only in an immature state
but may also have acquired a tolerogenic feature. As result
of our study showed, the extract at higher concentra-
tions decreased the proliferation of T cells in allogenic
response which is in line with the above results and
suggests the ability of the extract to affect T cell signaling
activity of DCs.
A major characteristic of DCs is synthesis and release of
cytokines with modulatory functions during inflammation
and T cell differentiation. Immune response is skewed to
humoral or cellular immunity based on cytokines secreted
by DCs. IL-12 is a cytokine expressed and released by DCs
which can induce differentiation of T cells to Th1 and cellu-
lar immunity, by contrast IL-10 is a Th1 inhibitory cytokine
[20,21]. An elevated IL-12 secretion level by DCs at con-
centrations of 0.1 and 1 μg/ml of the extract and no change
in IL-10 release was observed in this study. As IL-4 and
IFN-γ are landmark of deviation to Th1 or Th2, these cy-
tokines were measured in the supernatant of MLR assay.
The results indicated a decrease in IL-4 production versus
an increase in IFN-γ secretion at concentrations of 0.1
and 1 μg/ml of the extract. In a normal immune response,
splenic DCs expressing IL-12 in co-culture with T cells can
induce production of IFN-γ and deviation to Th1 while
neutralizing of IL-12 inhibit Th1 response and increase Th2
response [22]. Therefore, the increased IL-12 production by
DCs when they were treated with low concentrations of the
extract along with production of more IFN-γ and less IL-4
by T cells in MLR suggest the ability of C. intybus extract
to deviate the cytokine pattern of T cells toward a Th1 re-
sponse. Of note, the extract at concentration of 100 μg/ml
has reduced both IL-12 secretion by treated DCs and
IFN-γ release in MLR, which indicated the inhibitory
effect of the extract at higher concentration on the im-
mune response. It is reasonable to assume that the de-
creasing trend observed in the expression of MHC II
molecules on DCs, as mentioned before might be a
reason for the diminished T cells proliferation and cy-
tokines release observed at higher concentration of the
extract. To confirm Th1 polarization in co-culture of T
cells with C. intybus treated-DCs, study of the expression
of T bet and GATA-3 as related transcription factors for
Th1 and Th2 differentiation is recommended [23]. More-
over, the difference between the effect of the extract at
lower and higher concentrations may be attributed to thepresence of various constituents in the extract with dif-
ferent mode of actions. As we used ethanolic crude
root extract of the plant, it would be necessary to iden-
tify the compound/s responsible for the observed effects
in future studies.
Conclusions
C. intybus extract at higher concentrations inhibited T
cell stimulating activity of DCs. In contrast, at lower
concentrations the extract increased IL-12 production
by DCs and modulated cytokine release of T cells toward
a Th1 pattern.
Based on these findings further in vivo studies to elu-
cidate the effect of these compounds on the complex
pathways of DC regulation via IFN-γ and IL-4 as well
as their effects on other T cell subsets such as T regulatory
cells may lead to the development of clinical applications
exploiting these compounds for the treatment of various
immune diseases.
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Additional file 1: Figure S1. Effect of C. intybus ethanolic extract on
phenotypic maturation of DCs.
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